What is the step‑ladder approach to pain management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

WHO Step-Ladder Approach to Pain Management

The WHO analgesic ladder is a three-step sequential approach that matches analgesic intensity to pain severity: Step 1 uses non-opioids (paracetamol/NSAIDs) for mild pain, Step 2 adds weak opioids (codeine, tramadol) for moderate pain, and Step 3 uses strong opioids (morphine) for severe pain, with adjuvants available at all steps. 1, 2

The Three Steps Explained

Step 1: Mild Pain (Pain Score 1-3/10)

  • First-line: Paracetamol 1g every 4-6 hours (maximum 4g/day) 1
  • Alternative: NSAIDs for inflammatory or bone pain 1
  • Key caveat: Avoid NSAIDs with methotrexate, and use cautiously with nephrotoxic chemotherapy (cisplatin) or in patients with renal impairment 1

Step 2: Moderate Pain (Pain Score 4-6/10)

  • Weak opioids (codeine, tramadol, dihydrocodeine) combined with non-opioid analgesics 3
  • Alternative approach: Low-dose strong opioids instead of weak opioids 3, 1
  • Critical limitation: Step 2 typically provides adequate relief for only 30-40 days before requiring escalation 3

Step 3: Severe Pain (Pain Score 7-10/10)

  • First-choice: Oral morphine as the strong opioid of choice 3, 2
  • Alternatives: Fentanyl, oxycodone, hydromorphone, buprenorphine, methadone 2
  • Renal impairment: Use fentanyl or buprenorphine (transdermal or IV) when eGFR <30 ml/min 3

Five Essential Principles for Implementation

The WHO approach requires adherence to these core principles 1:

  1. Oral administration first - Use oral route whenever possible
  2. Regular dosing schedule - Around-the-clock administration, not "as needed" 3
  3. Appropriate step selection - Match to pain severity
  4. Individualized titration - Adjust based on response
  5. Attention to detail - Anticipate breakthrough pain and side effects

Practical Application Algorithm

Initial assessment: Use validated pain scales (VAS, NRS, or verbal rating scale) to quantify pain intensity 3, 2

Starting point:

  • Pain 1-3/10 → Start Step 1
  • Pain 4-6/10 → Start Step 2 (or consider low-dose Step 3)
  • Pain 7-10/10 → Start Step 3 directly 1
  • Exception: Very severe pain warrants immediate strong opioids regardless of prior treatment 1

Titration for strong opioids:

  • Use immediate-release morphine every 4 hours plus hourly rescue doses 3
  • Calculate total 24-hour requirement (scheduled + rescue doses)
  • Convert to sustained-release formulation for maintenance 3, 2
  • Prescribe breakthrough medication at 1/6 of total daily dose 2

Mandatory co-prescriptions:

  • Laxatives must be routinely prescribed with all opioids 3
  • Antiemetics (metoclopramide) for opioid-related nausea/vomiting 3

Adjuvant Medications at All Steps

Adjuvants can be added at any step based on pain mechanism 1:

  • Neuropathic pain: Anticonvulsants (gabapentin) or antidepressants
  • Bone pain: NSAIDs or bisphosphonates
  • Inflammatory pain: Corticosteroids (specific role in spinal cord compression, brain metastases)

The Step 2 Controversy

Emerging evidence challenges the utility of Step 2 2, 3, 4:

  • A 2022 randomized trial found no significant difference in time to pain control between weak opioids (Step 2) and low-dose strong opioids (Step 3) 4
  • 53% of patients on weak opioids required escalation to strong opioids (median time: 6 days) 4
  • Patients starting with strong opioids had less nausea and lower costs 4
  • However, systematic reviews show a "weak negative recommendation" against removing Step 2 due to higher side effects with direct strong opioid use 2

Clinical decision point: For rapidly worsening pain, consider bypassing Step 2 and starting low-dose strong opioids to avoid delayed adequate relief 2, 3

Common Pitfalls to Avoid

  1. Never combine two sustained-release opioids of the same class 1
  2. Don't prescribe "as needed" only - chronic cancer pain requires scheduled dosing 3
  3. Morphine dose conversion: Oral to IV/SC ratio is 1:2 to 1:3 3
  4. Weak opioid ceiling effect: Doses above threshold increase side effects without improving analgesia 3
  5. NSAIDs long-term: Risk of GI bleeding, renal failure, and cardiovascular events with prolonged use 3

Monitoring and Reassessment

  • Regular pain assessment using the same validated scale 3
  • Timing of step progression depends on analgesic duration of action and pain intensity 1
  • Expected success rate: 70-90% of patients achieve adequate pain control with proper WHO ladder application 2, 5
  • Written treatment plan should be provided to patients with clear instructions for breakthrough pain 1

When the Ladder Fails

If pain remains uncontrolled despite optimal Step 3 management:

  • Consider opioid rotation (especially for morphine toxicity with renal impairment)
  • Evaluate for interventional procedures (nerve blocks, epidural steroids)
  • Reassess pain mechanism (neuropathic component may require different adjuvants)
  • Ensure adequate adjuvant therapy is optimized

References

Related Questions

What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
1. What is the major health problem resulting from a pulse deficit? (A) Bradycardia (B) Activity intolerance (C) Decreased cardiac output (D) Impaired tissue perfusion. 2. What should the nurse do when a pulse deficit is suspected? (A) Measure the radial pulse for one minute, then measure the apical pulse for one minute (B) Measure the radial pulse for 30 seconds, then measure the apical pulse for 30 seconds (C) Measure the radial pulse for one minute, wait five minutes, then measure the apical pulse for one minute (D) Ask another health‑care provider to count the radial pulse while the nurse counts the apical pulse. 3. After identifying a pulse deficit, which action should the nurse perform? (A) Reassess the apical‑radial pulse in five minutes (B) Assess the patient for signs of decreased cardiac output (C) Notify the primary health‑care provider of the pulse deficit (D) Initiate interventions directed toward managing the patient’s symptoms. 4. A patient has oral temperature 36.8 °C, radial pulse 112 weak and thready, apical pulse 117 regular, respirations 24 regular, blood pressure 104/56 right arm, 102/50 left arm; what is the pulse deficit? (A) 2 (B) 5 (C) 6 (D) 48. 5. Which of the following is an early manifestation of decreased cardiac output? (A) Fatigue (B) Substernal pain (C) Nail‑bed cyanosis (D) Shortness of breath.
In a 24-year-old woman who experiences severe nausea, shakiness, and dizziness lasting about 30 minutes after sexual intercourse, what are the possible differential diagnoses?
How should a 2-year-old child presenting with a dry cough and wheezing be managed?
Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
What are the recommended oxybutynin dosing regimens for adults, elderly patients, patients with hepatic or renal impairment, and children ≥5 years old?
Can I start Mounjaro (tirzepatide) while taking mirtazapine 7.5 mg twice daily, sertraline 150 mg each morning, and clonazepam 0.25 mg at night?
Is taking finasteride 1 mg on alternate days sufficient for treating androgen‑dependent hair loss?
What alternative treatments can be used for a patient with major depressive disorder and insomnia who cannot take escitalopram (Lexapro), bupropion (Wellbutrin), mirtazapine, citalopram (Celexa), paroxetine, fluoxetine (Prozac), venlafaxine, or sertraline (Zoloft)?
How does SIADH impact a paraplegic/quadriplegic spinal cord injury patient who refuses his 25 mg electron medication due to polyuria?
Is it appropriate to prescribe prednisone 100 mg daily for five days to a patient with suspected lymphoma while awaiting biopsy results?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.